IMMvention
IMMvention is a biotech company in Durham, United States, founded in 2017.
IMMvention Therapeutix
- Headquarters
- Durham, North Carolina
- Employees
- 1–10
- Founded
- 2017
- Business Model
- B2B
- Website
- immventionthera.com
About
IMMvention Therapeutix is developing first-in-class BACH1 inhibitors with transformative potential as an oral therapy for patients with sickle cell disease (SCD) and beyond. The company has entered a strategic collaboration with Novo Nordisk to advance this program, and continues growing its pipeline of oral small-molecule therapeutics through ongoing research, development, and partnership activity focused on serious unmet medical needs.
Summary
It lists 1–10 employees.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/immvention"><img src="https://indexed.vc/api/badge/company/immvention" alt="IMMvention on Indexed.vc" width="260" height="76" /></a>